Polyphosphoinositides in the nucleus: Roadmap of their effectors and mechanisms of interaction by Jacobsen, Rhian Gaenor et al.
Contents lists available at ScienceDirect
Advances in Biological Regulation
journal homepage: www.elsevier.com/locate/jbior
Polyphosphoinositides in the nucleus: Roadmap of their effectors
and mechanisms of interaction
Rhîan G. Jacobsena, Fatemeh Mazloumi Gavgania,1, Amanda J. Edsona,
Marianne Gorisb, Altanchimeg Altankhuyagc,d, Aurélia E. Lewisa,∗
a Department of Biological Sciences, University of Bergen, Bergen, 5008, Norway
b NORCE Norwegian Research Center, Bergen, 5008, Norway
c Department of Biomedicine, University of Bergen, Bergen, 5021, Norway
d Department of Clinical Science, University of Bergen, Bergen, 5021, Norway








A B S T R A C T
Biomolecular interactions between proteins and polyphosphoinositides (PPIn) are essential in the
regulation of the vast majority of cellular processes. Consequently, alteration of these interactions
is implicated in the development of many diseases. PPIn are phosphorylated derivatives of
phosphatidylinositol and consist of seven species with different phosphate combinations. PPIn
signal by recruiting proteins via canonical domains or short polybasic motifs. Although their
actions are predominantly documented on cytoplasmic membranes, six of the seven PPIn are
present within the nucleus together with the PPIn kinases, phosphatases and phospholipases that
regulate their turnover. Importantly, the contribution of nuclear PPIn in the regulation of nuclear
processes has led to an increased recognition of their importance compared to their more ac-
cepted cytoplasmic roles. This review summarises our knowledge on the identification and
functional characterisation of nuclear PPIn-effector proteins as well as their mode of interactions,
which tend to favour polybasic motifs.
1. Introduction
Polyphosphoinositides (PPIn) (nomenclature as detailed in (Michell et al., 2006)) are phosphorylated derivatives of the glycer-
ophospholipid phosphatidylinositol (PtdIns), composed of two hydrophobic fatty acyl tails esterified to a glycerol backbone, which is
itself linked to the D-myo-inositol head group (Fig. 1A). Phosphorylation/dephosphorylation of the hydroxyl groups present on
positions 3, 4 and 5 of the inositol head group by PPIn kinases and phosphatases can produce seven distinct PPIn, i.e. three
monophosphorylated PPIn (PtdIns3P, PtdIns4P and PtdIns5P), three diphosphorylated (PtdIns(3,4)P2, PtdIns(3,5)P2 and PtdIns(4,5)
P2) and one triphosphorylated (PtdIns(3,4,5)P3) (Balla, 2013). The presence of acyl chains allows PPIn to be embedded in mem-
branes. On the other hand, the headgroup is exposed to the solvent where it can interact with proteins containing well-defined
structured PPIn-binding domains or short polybasic motifs (Hammond and Balla, 2015; Pemberton and Balla, 2018). In both cases,
interaction occurs through electrostatic interactions between basic residues and the phosphates displayed on the headgroup. De-
pending on the level and localisation of PPIn species, different proteins can be recruited to specific membrane locations in a timely
manner, hence providing the cell with a PPIn-dependent signalling code.
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Since the 1950s when the PPIn cycle was discovered, research efforts have focused on the biochemical and functional character-
isation of PPIn located at the plasma membrane and further on organelle membranes. It took at least another decade before the first
studies demonstrated the existence of phospholipids (Manzoli et al., 1977; Rose and Frenster, 1965) and then of PPIn within the
confines of the nucleus, i.e. separate from the nuclear envelope (Cocco et al., 1987; Payrastre et al., 1992). Indeed, not only were PPIn
detected in nuclei stripped of their nuclear envelope, but also their levels changed upon the addition of different cell stimuli (Clarke
et al., 2001; Cocco et al., 1989; Divecha et al., 1991). Since then, evidence has accumulated to detail the localisation of PPIn and the
identification of effector proteins in the nucleus. This led to the recognition of PPIn being instrumental in a number of different
nuclear processes such as splicing and chromatin remodelling (see recent reviews (Barlow et al., 2010; Davis et al., 2015; Fiume et al.,
2012; Hamann and Blind, 2018; Martelli et al., 2011; Shah et al., 2013)). Identifying which effector proteins these PPIn interact with
and understanding their mode of interaction are key to deciphering the functions of these lipids in the nucleus. This review focuses on
these two aspects.
2. Nuclear polyphosphoinositides and their metabolic enzymes
All PPIn, except PtdIns(3,5)P2, have been detected in the nucleus by using different approaches (Table 1 and reviewed in (Fiume
et al., 2012; Shah et al., 2013)). PtdIns3P has been detected in nuclei by the use of a specific probe consisting of two FYVE (Fab1p,
YOTB, Vac1p and EEA1) domains and electron microscopy (Gillooly et al., 2000). Mass levels of nuclear PtdIns4P, PtdIns5P and
PtdIns(4,5)P2 have been measured by radiolabelling (Clarke et al., 2001). PtdIns(4,5)P2 has also been identified in the nucleus using a
PtdIns(4,5)P2 specific probe, the pleckstrin homology (PH) domain of phospholipase C (PLC) δ1 combined with electron microscopy
(Watt et al., 2002). In addition, using immunostaining, PtdIns(4,5)P2 was detected in nuclear speckles along with mRNA-processing
components, in the newly described nuclear lipid islets as well as in nucleoli but as a minor detectable pool (Boronenkov et al., 1998;
Osborne et al., 2001; Sobol et al., 2013; Sobol et al., 2018; Yildirim et al., 2013). Using either a specific PtdIns(3,4,5)P3 probe (the PH
domain of general receptor of phosphoinositides 1) or antibodies, PtdIns(3,4,5)P3 was shown to localise to the nucleoplasm and
nucleolus (Karlsson et al., 2016; Kumar et al., 2010; Kwon et al., 2010; Lindsay et al., 2006).
Consistently, several PPIn metabolising enzymes are present in the nucleus, notably in discrete sub-nuclear areas common to the
localisation of their respective PPIn substrate and/or product (Table 2 and Fig. 1B). In particular, strong evidence shows the presence
of a PPIn metabolic cycle in nuclear speckles (alias inter chromatin granule clusters), hubs of mRNA processing in association with
transcriptional events (Spector and Lamond, 2011) and the nucleolus, the ribosome factory (Pederson, 2011). The type III PtdIns4Kα
and β isoforms, generating PtdIns4P, have been detected in nucleoli and nuclear speckles respectively (Kakuk et al., 2006, 2008;
Szivak et al., 2006). The β form, in particular, was found in nuclear speckles when phosphorylated on Serine 496 or Threonine 504,
while the Serine 294 phosphorylated enzyme is present on the Golgi (Szivak et al., 2006). The type I phosphatidylinositol phosphate
kinase (PIPKIα), which phosphorylates PtdIns4P to generate PtdIns(4,5)P2, has also been found in the nucleolus in G1/S phase and
shown to affect rRNA gene silencing through its physical association with H3K9me3 and heterochromatin protein 1α (Chakrabarti
et al., 2015). PIPKIα as well as PIPKIγ isoform 4, localise to nuclear speckles (Boronenkov et al., 1998; Mellman et al., 2008; Schill and
Abbreviations
ABP actin-binding protein
BASP1 brain acid soluble protein 1
BAZ2B BROMO domain adjacent to zinc finger 2B
CKIα casein kinase Iα
DAG diacylglycerol
EBP1 Erbb3 binding protein-1
FYVE Fab1p, YOTB, Vac1 and EEA1
GAP43 growth associated protein 43
HDAC1 histone deacetylase 1
ING2 inhibitor of growth protein 2
IP3 inositol 1,4,5-trisphosphate
IPMK inositol polyphosphate multikinase
K/R lysine/arginine motif following the motif K/R-(X3-
7)-K-X-K/ReK/R
LRH-1 liver receptor homolog-1
MARCKS myristoylated alanine-rich C-kinase substrate
NLS nuclear localisation signal
NoLS nucleolar localisation signal
N-WASP neuronal Wiskott-Aldrich syndrome protein
OGT O-linked beta-N-acetylglucosamine transferase
PBR polybasic region
Pf1 PHD factor 1
PH pleckstrin homology
PHD plant homeodomain




PIP3BP PtdIns(3,4,5)P3 binding protein
PIPK phosphatidylinositol phosphate kinase
PLC phospholipase C
Pol I/II RNA polymerase I/II
PPIn polyphosphoinositide
PtdIns phosphatidylinositol
PTEN phosphatase and tensin homolog deleted on chro-
mosome 10
RNP ribonucleoprotein
SAP30 sin3A-associated protein 30
SAP30L human SAP30-like protein
SF-1 steroidogenic factor-1
SHIP src homology 2 (SH2) domain containing inositol
phosphatase
TAF3 transcription initiation factor TFIID subunit 3
Topo IIα DNA topoisomerase IIα
UBF upstream binding factor
UHRF1 ubiquitin-like PHD and RING finger domain-con-
taining protein 1
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Anderson, 2009). These studies are consistent with the possible detection of PtdIns4P in nucleoli as well as nuclear speckles, as
reported by Kalasova et al., although no markers were used in the study (Kalasova et al., 2016). In addition, the type II PIPKα and β,
which phosphorylate PtdIns5P to generate PtdIns(4,5)P2, are also present in nuclear speckles (Boronenkov et al., 1998). PLCβ1, which
metabolises PtdIns(4,5)P2 to diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3), has also been found in the nucleus and in
particular in nuclear speckles (Manzoli et al., 1995; Martelli et al., 1992; Tabellini et al., 2003). Other isoforms are also known to be
nuclear, such as PLCδ1 and δ4 (Kunrath-Lima et al., 2018; Okada et al., 2010). Finally, consistent with the presence of a PtdIns(3,4,5)
Fig. 1. Nuclear polyphosphoinositide metabolism. A) Phosphatidylinositol (PtdIns) structure PI(18:0/20:4 (5Z,8Z,11Z, 14Z)) downloaded from the
LIPID MAPS structure database (LM ID: LMGP06010010) (Fahy et al., 2009; Sud et al., 2007). Hydroxyl groups that are sites of phosphorylation on
the inositol head group are indicated with arrows and carbon atom numbers are shown in red. B) Nuclear polyphosphoinositide cycle. Polypho-
sphoinositide kinases and phosphatases as well as phospholipases known to reside in the nucleus are shown (see also Table 2). Abbreviations: 4-
Ptase: 4-phosphatase, DAG: diacylglycerol, IP3: inositol 1,4,5-trisphosphate, IPMK: inositol polyphosphate multikinase, P: phosphate group, PI3K:
phosphoinositide 3-kinase, PI4K: phosphatidylinositol 4-kinase, PIPK: phosphatidylinositol phosphate kinase, PLC: phospholipase C, PTEN: phos-
phatase and tensin homolog deleted on chromosome 10, SHIP: src homology 2 (SH2) domain containing inositol phosphatase.
Table 1
Nuclear localisation of polyphosphoinositides.
PPIn Sub-nuclear localisation (References)
PtdIns3P Nucleolus (Gillooly et al., 2000)
PtdIns4P Nucleus (Clarke et al., 2001; Kalasova et al., 2016; Vann et al., 1997)
Nucleolus (Kalasova et al., 2016)
PtdIns5P Nucleus and chromatin enriched fraction, detected upon stress induction (Clarke et al., 2001; Jones et al., 2006)
PtdIns(3,4)P2 Nuclear membrane (Watt et al., 2004; Yokogawa et al., 2000)
PtdIns(4,5)P2 Interchromatin granules/Nuclear speckles (Boronenkov et al., 1998; Osborne et al., 2001)
Nucleolus (Kalasova et al., 2016; Osborne et al., 2001; Sobol et al., 2013; Yildirim et al., 2013)
Nuclear lipid islets (Sobol et al., 2018)
PtdIns(3,4,5)P3 Nuclear matrix (Kumar et al., 2010; Kwon et al., 2010; Lindsay et al., 2006)
Nucleolus (Karlsson et al., 2016)
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P3 pool in the nucleus and nucleolus, enzymes generating (class IA phosphoinositide 3-kinase (PI3K) p110β) or metabolising PtdIns
(3,4,5)P3 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and src homology 2 (SH2) domain containing inositol
phosphatase (SHIP) 1/2) have been detected in the nucleus. In particular, the PI3K catalytic subunit p110β harbours a nuclear
Table 2
Nuclear PPIn-metabolising enzymes, their substrates and nuclear localisation.
Nuclear PPIn kinases
Enzyme Substrate Sub-nuclear localisation (References)
Type IIIα PI4K PI4K230 PtdIns Nucleolus (Kakuk et al., 2006, 2008)
Type IIIβ PI4K PI4K92 PtdIns Nucleus (de Graaf et al., 2002)
> Nuclear speckles (Szivak et al., 2006)
Type Iα PIPK PtdIns4P Nuclear speckles (Boronenkov et al., 1998; Mellman et al., 2008)
Nucleolus (Chakrabarti et al., 2015)
Type Iγ PIPK_i4 PtdIns4P Nuclear speckles (Schill and Anderson, 2009)
Type IIα PIPK PtdIns5P Nucleus (Bultsma et al., 2010)
Nuclear speckles (Boronenkov et al., 1998)
Type IIβ PIPK PtdIns5P Nucleus (Bultsma et al., 2010; Ciruela et al., 2000)
Class I PI3K, p110β PtdIns(4,5)P2 Nucleoplasm, chromatin, double stranded break foci (Kumar et al., 2010, 2011;
Marques et al., 2009)
Nucleolus (Karlsson et al., 2016)
IPMK PtdIns(4,5)P2 Nucleus (Resnick et al., 2005)
Class IIα PI3K PtdIns, PtdIns4P Nuclear speckles (Didichenko and Thelen, 2001)
Class IIβ PI3K PtdIns, PtdIns4P Nuclear matrix (Sindic et al., 2001) Nuclear lamina (Banfic et al., 2009)
Nuclear PPIn phosphatases
Enzyme Substrate Sub-nuclear localisation (References)
PTEN PtdIns(3,4,5)P3 Nucleus (Deleris et al., 2003; Shen et al., 2007; Song et al., 2008)
Nucleolus (Li et al., 2014), PTENβ (Liang et al., 2017)
SHIP1 PtdIns(3,4,5)P3 Nucleolus (Ehm et al., 2015)
SHIP2 PtdIns(3,4,5)P3 or PtdIns(4,5)
P2?
Nuclear speckles (Deleris et al., 2003; Elong Edimo et al., 2011)
Type I PtdIns(4,5)P2 4-phosphatase PtdIns(4,5)P2 Translocates to the nucleus upon cell stress (Zou et al., 2007)
Nuclear phospholipase C
Enzyme Substrate Sub-nuclear localisation (References)
PLCβ1 PtdIns(4,5)P2 Nuclear speckles (Tabellini et al., 2003)
PLCδ1 PtdIns(4,5)P2 Nucleus (Okada et al., 2010)
PLCδ4 PtdIns(4,5)P2 Nucleus (Kunrath-Lima et al., 2018)
Abbreviations: IPMK: inositol polyphosphate multikinase, PI3K: phosphoinositide 3-kinase, PI4K: phosphatidylinositol 4-kinase, PIPK: phosphati-
dylinositol phosphate kinase, PLC: phospholipase C, PPIn: polyphosphoinositide, PtdIns: phosphatidylinositol, PTEN: phosphatase and tensin
homolog deleted on chromosome 10, SHIP: src homology 2 (SH2) domain containing inositol phosphatase.
Fig. 2. Modes of protein interaction with polyphosphoinositides in the nucleus. Schematic representation of different modes of PPIn interaction in
the following nuclear proteins in A) ligand binding domain (LBD) of steroidogenic factor-1 (SF-1) shielding the acyl chains of a representative PPIn
(Blind et al., 2014), B) Erbb3 binding protein-1 (EBP1) showing the human sequence of the C-terminal unstructured region including the K/R motif
(Karlsson et al., 2016) and C) Inhibitor of growth 2 (ING2), showing the human sequence of the plant homeodomain (PHD) with the polybasic region
(PBR) (Gozani et al., 2003; Huang et al., 2007). Hydrophobic regions/interactions are indicated in orange. Basic residues are shown in blue. Basic
residues which have been mutated and implicated in binding are indicated with +. Illustrations are not drawn to scale.
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localisation signal (NLS) and was shown to be important for DNA replication, DNA repair and cell survival (Kumar et al., 2010, 2011;
Marques et al., 2009). However, some of the reported nuclear functions of p110β have been shown to be kinase-independent (Kumar
et al., 2010; Marques et al., 2009). Regarding a possible nucleolar role for p110β, one study showed that p110 (likely β) interacts,
phosphorylates and activates the ribosomal DNA transcription factor, upstream binding factor (UBF), in the nucleus upon insulin
growth factor-1 stimulation (Drakas et al., 2004). This study did not however evaluate the lipid kinase activity of p110(β). Alter-
natively, inositol polyphosphate multikinase (IPMK), found in the nucleus, has PI3K activity (Maag et al., 2011; Resnick et al., 2005)
and was shown to phosphorylate PtdIns(4,5)P2-bound to steroidogenic factor-1 (SF-1) to PtdIns(3,4,5)P3 (Blind et al., 2012). The
phosphatases PTEN and SHIP1/2, which dephosphorylate PtdIns(3,4,5)P3 to produce PtdIns(4,5)P2 and PtdIns(3,4)P2 respectively,
are also present in the nucleus (Deleris et al., 2003; Ehm et al., 2015; Elong Edimo et al., 2011; Shen et al., 2007). SHIP2 has been
found in nuclear speckles when phosphorylated on Serine 132 and suggested to use PtdIns(4,5)P2 as a substrate rather than PtdIns
(3,4,5)P3 in vivo (Deleris et al., 2003; Elong Edimo et al., 2011). The nuclear roles of PTEN are thought to be either dependent (Liu
et al., 2005) or independent of its lipid phosphatase activity (Lindsay et al., 2006; Shen et al., 2007; Song et al., 2011). PTEN has also
been found in promyelocytic leukaemia protein (PML) bodies, at the centromere and in nucleoli (Li et al., 2014; Shen et al., 2007;
Song et al., 2008). The class II PI3Ks α and β, which can produce PtdIns3P or PtdIns(3,4)P2, are found in nuclear speckles or in the
nuclear matrix in association with lamin A/C, respectively (Banfic et al., 2009; Didichenko and Thelen, 2001; Sindic et al., 2001).
One fundamental question about the presence of PPIn within the nucleus is how their hydrophobic tails are shielded from the
aqueous environment. Although our understanding of the biophysical nature of these PPIn in the nucleus remains incomplete, several
possibilities have been proposed. Recent elegant structural studies demonstrated the acyl chains to be buried in the hydrophobic
ligand binding pocket of the nuclear receptors (NR) SF-1/NR5A1 ((Blind et al., 2012, 2014), as represented in Fig. 2A) and liver
receptor homolog-1 (LRH-1/NR5A2) (Sablin et al., 2015), allowing the exposure of the inositol head group to the action of PPIn
kinases and phosphatases (Blind et al., 2012). Alternatively, the formation of micelles, perhaps with the abundant nuclear phos-
pholipid phosphatidylcholine (Hunt et al., 2001), has been suggested but not demonstrated so far (Barlow et al., 2010; Irvine, 2006).
Recently, a new type of nuclear structure referred to as nuclear lipid islets (NLIs) has been described as PtdIns(4,5)P2 nuclear
aggregates, possibly in the form of micelles with acyl chains facing inwards (Sobol et al., 2018; Sztacho et al., 2019). These structures
are suggested to serve as platforms for RNA polymerase II (pol II) as an integral part for mRNA pol II transcription. Lipid droplets
have also been documented in the nucleus (Layerenza et al., 2013) as well as in expansions of the inner nuclear membrane
(Romanauska and Kohler, 2018) and may act as reservoir of PPInin their monolayer. In whatever physico-chemical structure PPIn
may be found in the nucleus, another issue is still unanswered: how is PtdIns transferred from its site of synthesis in the endoplasmic
reticulum to the nucleus for the local action of PPIn kinases and phosphatases? Answering this question will in no doubt give the field
of nuclear PPIn greater recognition.
3. Nuclear polyphosphoinositide functions
Elucidating interaction partners for nuclear PPIn is fundamental to understanding the role they play in the nucleus. Several
studies have begun to shed light on nuclear PPIn effector proteins and the influence PPIn have on diverse key nuclear processes.
3.1. Nuclear PPIn in chromatin remodelling and gene transcription
PPIn have been linked to several aspects of chromatin remodelling and regulation of gene transcription. PPIn modulating the
interaction of PPIn-binding proteins with chromatin is one potential mechanism by which PPIn influence these processes (Viiri et al.,
2012). Some of these interactions are regulated via PtdIns5P, which although normally found at low levels in cells, increases in the
nucleus in response to different types of cellular stress (Clarke et al., 2001; Jones et al., 2006; Zou et al., 2007). PtdIns5P binds to
several nuclear proteins involved in chromatin remodelling harbouring a plant homeodomain (PHD)-type zinc finger. PHD zinc
fingers can bind to methylated lysines in histone tails while other parts of the protein can recruit chromatin-remodelling complexes
(Sanchez and Zhou, 2011). One of these proteins is the histone code reader, inhibitor of growth protein 2 (ING2), a component of the
transcriptional co-repressor Sin3a-histone deacetylase 1 (HDAC1) complex (Bua et al., 2013; Gozani et al., 2003). PtdIns5P con-
tributes to the localisation of ING2 in the nucleus where it associates with the chromatin (Gozani et al., 2003; Jones et al., 2006). This
is indeed counteracted by the overexpression of the type II PtdIns5P 4-kinase β, which decreases the levels of PtdIns5P. Over-
expression of ING2 induces p53 acetylation and p53-dependent induction of apoptosis and this activity was shown to be dependent
upon an intact PPIn-binding motif (Gozani et al., 2003; Zou et al., 2007). In response to etoposide-induced DNA damage in particular,
PtdIns5P was demonstrated to be required for the association of ING2 with target gene promoters leading to their transcriptional
repression (Bua et al., 2013). Interaction of all three mono-phosphorylated PPIn with the co-repressor sin3A-associated protein 30-
like (SAP30L) was reported to decrease its association with chromatin in vitro and to reduce its transcriptional repression activity
(Viiri et al., 2009). Association of the basal transcription initiation factor TFIID subunit 3 (TAF3) with PPIn, including PtdIns5P, was
shown to be required for TAF3-regulated gene transcription necessary for muscle differentiation (Stijf-Bultsma et al., 2015). In plants,
the extended PHD finger of Arabidopsis homolog of trithorax ATX1 binds selectively to PtdIns5P, which leads to its translocation from
the nucleus to the cytoplasm, and a decrease in the transcriptional activity of ATX1 (Alvarez-Venegas et al., 2006; Ndamukong et al.,
2010). Furthermore, interaction of Ubiquitin-like PHD and RING finger domain-containing protein 1 (UHRF1) with PtdIns5P leads to
a conformational change allowing binding of UHRF1 to H3K9me3 (Gelato et al., 2014).
Other nuclear factors are influenced by PtdIns(4,5)P2. The role of this PPIn is associated with chromatin remodelling as it allows
the retention of BRG1, a component of the SWI/SNF-like BRG/BRM-associated factors (BAF) chromatin-remodelling complex in the
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nucleus and in particular on the chromatin (Zhao et al., 1998). PtdIns(4,5)P2 binds to a basic motif in the C-terminal part of BRG1 and
enhances actin filament binding (Rando et al., 2002). The functional consequence of this interaction is, however, not clear. What is
known is that actin plays roles in transcription (Visa and Percipalle, 2010) and may hence influence the action of the BAF complex,
and this, in turn, may be regulated by PtdIns(4,5)P2.
Association of the myristoylated corepressor brain acid soluble protein 1 (BASP1) with PtdIns(4,5)P2 is a requisite for HDAC1
binding at gene promoters regulated by Wilms’ tumour 1 protein, and the subsequent repression of these genes (Toska et al., 2012).
The nuclear receptors SF-1 (Blind et al., 2014) and LRH-1 (Sablin et al., 2015) interact with PPIn via their hydrophobic ligand-binding
pockets while leaving the inositol head group exposed to possible modification (Fig. 2A). Interestingly, the phosphorylation status of
the PPIn associated with SF-1 has been shown to be critical for transcriptional activity, with phosphorylation of PtdIns(4,5)P2 to
PtdIns(3,4,5)P3 by IPMK associated with higher transcriptional activity and dephosphorylation by PTEN to PtdIns(4,5)P2 with re-
duced activity (Blind et al., 2012). Alternatively, histones H1 and H3 themselves have also been identified as PtdIns(4,5)P2-binding
proteins and PtdIns(4,5)P2 was identified to interacte with the C-terminal of H1 (Yu et al., 1998). The authors further demonstrate
that PtdIns(4,5)P2 can alleviate the inhibition of mRNA pol II transcription imposed by H1 in vitro. Most recently, Choi et al. have
shown that both nuclear PtdIns(4,5)P2 and PIPKIα interact with the tumour suppressor p53, which increases its stability during
cellular stress (Choi et al., 2019).
3.2. PPIn in nucleolar processes
Several PPIn species have been detected in the nucleolus, including PtdIns3P, PtdIns(4,5)P2, PtdIns(3,4,5)P3 and perhaps also
PtdIns4P (Gillooly et al., 2000; Kalasova et al., 2016; Karlsson et al., 2016; Osborne et al., 2001; Sobol et al., 2013; Yildirim et al.,
2013). PtdIns(4,5)P2 was shown to bind to RNA pol I and to be necessary for transcription at the rDNA promoter (Yildirim et al.,
2013). In addition, PtdIns(4,5)P2 binds both to UBF and fibrillarin, which resulted in a reduction of binding of UBF to rDNA and
altered mobility of the fibrillarin/snRNA complex, suggesting a possible competitive mode of action. Furthermore, PtdIns(4,5)P2
engages with Pol I subunits and UBF during mitosis and co-localisation is maintained even when Pol I or II transcription is inhibited,
suggesting that PtdIns(4,5)P2 is part of the nucleolar organising region (NOR) complex of which the organisation is cell cycle de-
pendent (Sobol et al., 2013). Recently, PtdIns(4,5)P2 has been shown to regulate the levels of H3K9me2 at the rDNA promoter by
binding to and inhibiting the activity of the histone lysine demethylase PHD finger protein 8 (PHF8), likely resulting in a reduction in
rRNA gene transcription (Ulicna et al., 2018). Consistent with these studies showing a role for PtdIns(4,5)P2 in nucleolar processes,
PIPKIα, one of the PPIn kinases generating PtdIns(4,5)P2 using PtdIns4P, was found in the nucleolus in the G1/S phase of the cell
cycle (Chakrabarti et al., 2015). PIPKIα associates with H3K9me3 and plays roles in rDNA gene silencing. Whether or not the action of
PIPKIα is due to its lipid kinase acitivty was not investigated, but in light of the study of Ulicna et al., this mechanism would be worth
exploring.
3.3. Nuclear PPIn and cell survival
Nuclear PI3K activity and PtdIns(3,4,5)P3 have been shown to mediate the anti-apoptotic response to nerve growth factor (NGF)
together with the effector protein, nucleophosmin (alias B23) (Ahn et al., 2004, 2005). Upon the addition of NGF, PtdIns(3,4,5)P3
regulates the interaction of nucleophosmin with caspase-activated DNase (CAD), thereby preventing its nuclease activity and DNA
fragmentation (Ahn et al., 2005). The interaction between PtdIns(3,4,5)P3 and nucleophosmin in particular was required for the
prevention of cell death. Additionally, nucleophosmin associates with active Akt in the nucleus following NGF stimulation, which
increases its stability and enhances cell survival (Lee et al., 2008). The GTPase phosphatidylinositol 3 (PI3)-kinase enhancer (PIKE)-L
(now known as Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2), is another nuclear protein which binds to
PtdIns(3,4,5)P3, and contributes to cell survival through activation of PI3K and Akt (Hu et al., 2005).
3.4. PPIn in mRNA processing and export
Nuclear speckles (also known as interchromatin granule clusters) are nuclear hubs in which pre-mRNA splicing factors con-
gregate, but also contain a variety of other proteins (Galganski et al., 2017; Spector and Lamond, 2011). Localisation of PtdIns(4,5)P2
to nuclear speckles was evident with its co-detection with speckle markers such as the splicing factor SC-35 or Sm proteins
(Boronenkov et al., 1998; Osborne et al., 2001). Nuclear PtdIns(4,5)P2 interacts with components of small nuclear ribonucleoproteins
(RNP), the hyperphosphorylated form of the large subunit of RNA pol II and U1-U6 snRNAs (Osborne et al., 2001). The same study
also showed that its immunodepletion inhibited splicing of pre-mRNAs in vitro. Other nuclear speckle-associated proteins are also
known to interact with PPIn. Aly (alias THO complex subunit 4), for example, can associate with PtdIns(4,5)P2 and PtdIns(3,4,5)P3
and mutation of key basic residues prevented PtdIns(3,4,5)P3-binding and reduced Aly-mediated mRNA export activities and cell
proliferation (Okada et al., 2008). Moreover, PtdIns(3,4,5)P3, produced by IPMK, was shown to regulate Aly-mediated recognition of
specific mRNAs for nuclear export, particularly for those involved in homologous recombination DNA repair (Wickramasinghe et al.,
2013). Furthermore, a study searching for nuclear proteins interacting with the nuclear PIPKIα, identified the non-canonical poly(A)
polymerase called nuclear speckle targeted PIPKIα regulated-poly(A) polymerase (Star-PAP), and showed that PtdIns(4,5)P2 directly
stimulates the polyadenylation activity of target mRNAs (Mellman et al., 2008). Further studies from the same group demonstrated
that casein kinase Iα (CKIα), which is also PtdIns(4,5)P2-sensitive, is part of the Star-PAP complex together with PIPKIα and can
regulate Star-PAP activity targeting the 3′-end mRNA processing of select mRNAs (Gonzales et al., 2008).
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Collectively, these studies clearly demonstrate the far-reaching influence that PPIn have on nuclear events via their interaction
with an array of different effector proteins.
4. Mapping polyphosphoinositide-protein interactomes to understand their function
4.1. PPIn interactomic studies
To globally capture PPIn binding proteins, multiple studies have taken a proteomic approach ((Best, 2014; D'Santos and Lewis,
2012) and listed in Table 3). Affinity matrices containing synthetic PPIn followed by mass spectrometric fingerprinting have been
used to isolate PtdIns(3,4,5)P3-binding proteins in pig leukocytes (Krugmann et al., 2002). A chemical proteomics method using
cleavable lipid baits has also been used in macrophage whole cell extracts to identify mostly PtdIns(3,4)P2 interacting proteins
(Pasquali et al., 2007). Other studies using PPIn pull downs to identify interacting proteins included bifunctional activity-based
probes. In this approach, target proteins were labelled using PPIn head groups containing both a photo affinity tag to bind the
proteins and a secondary tag for analysis (Rowland et al., 2011). With the advancement of mass spectrometry, more quantitative
methods have been employed. Bead immobilized or liposomes incorporated PPIn have been used to identify PtdIns3P, PtdIns(3,5)P2,
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 target proteins in colorectal carcinoma cytosolic extracts (Catimel et al., 2008, 2009, 2013). To
discriminate specific PPIn binders from background proteins, quantitative approaches such as stable isotope labelling by amino acids
in cell culture (SILAC) have been employed (Dixon et al., 2011; Jungmichel et al., 2014; Lewis et al., 2011). Alternative strategies
include the analysis of yeast cDNA libraries combined with FACS-dependent identification of fluorescent PPIn binding clones for the
identification of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 binding proteins (Bidlingmaier et al., 2011).
4.2. Nuclear PtdIns(4,5)P2 interactome
To map the nuclear PPIn-protein interaction networks, we established an approach allowing the enrichment of nuclear PPIn-
interacting proteins by incubating nuclei with the polyamine neomycin (Lewis et al., 2011). Due to the high affinity of neomycin for
PPIn via electrostatic interactions (Gabev et al., 1989; Schacht, 1976, 1978, 1979), neomycin was predicted to compete with proteins
for binding to PPIn. By incubating isolated nuclei with neomycin, PPIn-binding proteins were displaced, allowing their collection and
identification by quantitative mass spectrometry. Using this approach, 349 proteins specifically displaced by neomycin from intact
nuclei were identified with enriched functions in DNA topological change, nucleosome positioning/assembly, chromatin assembly,
ribosome biogenesis, rRNA processing, mRNA splicing and processing (Lewis et al., 2011). Amongst them, a few known PPIn-effector
proteins were identified such as Aly (Okada et al., 2008), histone H1 (Yu et al., 1998) and nucleophosmin (Ahn et al., 2005) as well as
several speckle-associated proteins with RNA splicing functions (Osborne et al., 2001). However, many of the neomycin-displaced





Method Cell type/subcellular compartment Reference
PtdIns(3,4,5)P3 PPIn conjugated beads and MS Pig leukocyte cytosolic extract (Krugmann et al.,
2002)
Mostly PtdIns(3,4)P2 PPIn conjugated to cleavable S-S bond biotin + streptavidin
beads and MS
Primary macrophage cytosolic extract (Pasquali et al., 2007)
PtdIns(4,5)P2 Biotinylated PPIn, streptavidine conjugated beads and MS Secretory granules from bovine adrenal
chromaffin cells
(Osborne et al., 2007)
PtdIns(3,5)P2 & PtdIns
(4,5)P2
PPIn conjugated beads or liposomes and MS LIM1215 colon cancer cell cytosolic
extract
(Catimel et al., 2008)
PtdIns(3,4,5)P3 PPIn conjugated beads or liposomes and MS LIM1215 colon cancer cell cytosolic
extract
(Catimel et al., 2009)
PtdIns(4,5)P2 PPIn conjugated beads and quantitative MS Neomycin extracted nuclear proteins
isolated from murine erythroleukemia
cells
(Lewis et al., 2011)
PtdIns(3,4)P2 Stimulation of class I PI3K ± wortmannin, biotinylated PPIn
coupled to streptavidin beads and SILAC-based quantitative
MS
1321N1 astrocytoma membrane fractions (Dixon et al., 2011)
PtdIns(4,5)P2 and
PtdIns(3,4,5)P3
yeast surface-displayed human protein fragment
libraries + fluorescent PPIn
N/A (Bidlingmaier et al.,
2011)
PtdIns(3,4,5)P3 PPIn activity probe for click chemistry and MS MDA-MB-435 cancer cell cytosolic extract (Rowland et al., 2011)
PtdIns3P PPIn conjugated beads or liposomes and MS LIM1215 colon cancer cell cytosolic,
membrane and nuclear extracts
(Catimel et al., 2013)
All PPIn Triple SILAC-based quantitative MS HeLa S3 whole cell extract (Jungmichel et al.,
2014)
Table updated from (D'Santos and Lewis, 2012). SILAC: stable isotope labeling by amino acids in cell culture; MS: mass spectrometry; N/A: not
applicable.
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binding of DNA topoisomerase IIα (Topo IIα), for example, was validated and an inhibitory effect of PPIn on kDNA decatenation
activity was demonstrated, suggesting a role for PPIn in the regulation of DNA topological changes (Lewis et al., 2011). Other
neomycin-extracted proteins were subsequently verified to interacte with PPIn and include Erbb3 binding protein-1 (EBP1, alias
proliferation-associated protein 2G4, PA2G4) (Karlsson et al., 2016), PHF8 (Ulicna et al., 2018) and UHRF1 (Gelato et al., 2014).
Additionally, neomycin extracts were subjected to quantitative interactomics following PtdIns(4,5)P2 lipid-pull down and this led to
the identification of 34 PtdIns(4,5)P2-binding proteins, 28 of which were annotated to the nucleus, and known to be involved in
mRNA transcription regulation, mRNA splicing and protein folding/complex assembly (Lewis et al., 2011). Two of these proteins
were subsequently found common to the PtdIns(4,5)P2-binding proteins identified by the PPIn interactomics study by Jungmichel
et al. (2014),i.e. Elongation factor 1-delta and TBC1 domain family member 24.
5. Nuclear polyphosphoinositide-protein modes of interaction – polybasic regions lead the way
5.1. Diverse modes of interactions for PPIn-binding proteins
Proteins interact with PPIn via domains of diverse structure and PPIn binding specificities and affinities. They include the
Table 4
Polybasic motifs involved in polyphosphoinositide-protein interaction.
Actin-binding and membrane-binding proteins
Sequence Protein Motif type Reference
135-KSGLKYKK
161-KLFQVKGRR
Gelsolin K/R (Yu et al., 1992)




Villin K/R (Bazari et al., 1988; Kumar et al., 2004)
13-KVFNDMKVRK Cofilin K/R (Matsuzaki et al., 1988; Yu et al., 1992)
127-KCYEMASHLRR Profilin I K/R-like (Lassing and Lindberg, 1985; Skare and Karlsson, 2002; Lambrechts et al.,
2002)
151-KKKKKRFSFKKSFKLSGFSFKKNKK MARCKS K/R-like (Wang et al., 2001)
30-KAHKAATKIQASFRGHITRKKLKGEKK GAP43b K/R-like (Laux et al., 2000)
183-KEKKKGKAKKKRLTK N-WASP PBR (Papayannopoulos et al., 2005)
Nuclear PPIn-binding proteins
Sequence Protein Motif type Reference
105-RRKKREQKK Pf1 K/R, PBR (Kaadige and Ayer, 2006)
123-RNRRKRK SAP30 PBR (Viiri et al, 2009)
85-RNKRKRK SAP30L PBR (Viiri et al, 2009)
264-KTMDKSTEKTKKDRRSR ING2 PBR (Gozani et al., 2003)
1-60 region including a polybasic motifc BASP1 (alias NAP-
22)
PBR (Terashita et al., 2002)
641-RTGKGKWKRKSAGGGPS UHRF1 PBR (Gelato et al., 2014)
918-IKKDKKHKKRKHRAH TAF3 PBR (Stijf-Bultsma et al., 2015)







(Karlsson et al., 2016)
PHD-BRD linkere BAZ2B K/R (Kostrhon et al., 2017)
827-KSRPKKKK PHF8 K/R, PBR (Ulicna et al., 2018)
K194,K200 and K228,K234 NPM PBR? (Ahn et al., 2005)
981-KKVRGKVWKQRISSPLFNTK OGT Reverse K/R (Yang et al., 2008)
1402-EEVRQKKSSRKRKRDS BRG1 K/R, PBR (Rando et al., 2002)
370-KSKKGQSTSRHKK p53 PBR (Choi et al., 2019)
Basic residues in bold indicate residues shown to be required for PPIn interaction. BASP1: brain acid soluble protein 1, BAZ2B: BROMO domain
adjacent to zinc finger 2B, EBP1: Erb 3 binding protein-1, GAP43: Growth Associated Protein 43, ING2: inhibitor of growth protein 2, NPM:
nucleophosmin, OGT: O-linked beta-N-acetylglucosamine transferase, Pf1: PHD factor 1, PHF8: PHD finger protein 8, N-WASP: neuronal Wiskott-
Aldrich syndrome protein, SAP30: Sin3A-associated protein 30, SAP30L: human SAP30-like protein, TAF3: Transcription initiation factor TFIID
subunit 3, UHRF1: E3 ubiquitin-protein ligase UHRF1. K/R: lysine/arginine motif following the motif K/R-(X3-7)-K-X-K/ReK/R, PBR-polybasic
region.
a Recommended protein name: macrophage-capping protein.
b Recommended protein name: neuromodulin.
c The basic motif lies between aa 4–10 (1-MGGKLSKKKKGYNVN) of the first 60 aa shown to bind to PPIn.
d Isoform 1 also known as p48.
e PHD-BRD linker:1982-ASGQTLKIKKLHVKGKKTNESKKGKKVTLTGDTEDEDSASTSSSLKRGNKDLKKRKMEENTSINLSKQESFT.
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following domains: PH, FYVE, PX (Phox homology), ENTH/ANTH (epsin amino-terminal homology), FERM (band 4.1, ezrin, radixin
and moesin), PROPPIN and TRAF (Choy et al., 2017; Hammond and Balla, 2015; Kutateladze, 2010; Pemberton and Balla, 2018).
Alternatively, short polybasic PPIn-binding motifs or regions (PBR) have also been reported to interact with PPIn (Janmey et al.,
2018; McLaughlin and Murray, 2005; Yin and Janmey, 2003). These motifs consist of short stretches of basic amino acids, often
denoted as lysine/arginine-rich patches/clusters or KR-motifs (K/R-(X3-7)-K-X-K/ReK/R), first identified in the actin-binding protein
(ABP) gelsolin (Martin, 1998; Yu et al., 1992). Gelsolin is a multifunctional protein involved in cytoskeletal remodelling by severing
and capping actin filaments. This activity is regulated by PtdIns(4,5)P2 interacting at the same site as the actin-binding site (Feng
et al., 2001; Yu et al., 1992). KR-motifs have been identified in many PPIn-binding cytoskeletal proteins of the gelsolin family, such as
gCap39, villin, cofilin and profilin and the Wiskott Aldrich syndrome protein (WASP) ((Janmey et al., 2018) and Table 4). These
motifs rely on electrostatic interactions between their basic residues and the negatively charged phosphate groups. In addition,
hydrophobic residues can also contribute to the interaction to the acyl chains of PPIn, as shown for gelsolin and cofilin (Feng et al.,
2001; Gorbatyuk et al., 2006; Janmey and Stossel, 1987). Some of these ABPs known to engage in PtdIns(4,5)P2 interaction in the
cytoplasm can also be found in the nucleus (reviewed in (Barlow et al., 2010)). For example, profilin I, which binds to PtdIns(4,5)P2
via two motifs, one of them overlapping with the actin binding site, is also present in nuclear speckles as well as cajal bodies, and has
been implicated in mRNA splicing (Lambrechts et al., 2002; Skare and Karlsson, 2002; Skare et al., 2003). Other ABPs, such as N-
WASP (Wu et al., 2006), gCAP39 (Onoda and Yin, 1993; Onoda et al., 1993), as well as cofilins (Munsie et al., 2012), have also been
detected in the nucleus in addition to the cytoplasm. To the best of our knowledge, the functional role(s) of the interaction with PPIn
have however not been explored in the regulation of nuclear processes thought to be mediated by these proteins.
Another well characterized example of PPIn-binding motif can be found in the myristoylated alanine-rich C-kinase substrate
(MARCKS) and growth-associated protein 43 (GAP43) proteins ((Laux et al., 2000; Wang et al., 2002) see Table 4). MARCKS and
GAP43 anchor into the bilayer through an N-terminal myristate and two saturated acyl chains respectively, and bind electrostatically
to a cluster of PtdIns(4,5)P2 via a conserved effector domain, consisting of a K/R like PBR. The membrane interaction of MARCKS is
regulated by phosphorylation of serine residues located within the effector domain by protein kinase C, resulting in a reduction of the
electrostatic attraction between the protein and PPIn and causing MARCKS to dissociate from the plasma membrane and to trans-
locate to the cytoplasm (McLaughlin and Murray, 2005; Ohmori et al., 2000). Interestingly, MARCKS has also been detected in the
nucleus due to its effector domain acting as an NLS (Rohrbach et al., 2015).
Many small GTPases in the Ras and Rho families harbour C-terminal PBR consisting of four or more lysine or arginine residues,
responsible for their association with the plasma membrane via PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (Heo et al., 2006). In the case of the
small GTPase Rac1, the polybasic motif was demonstrated to also act as a functional NLS (Lanning et al., 2003). The presence of
canonical NLS sequences (K-K/R-x-K/R) in the polybasic motif of several Ras and Rho family members indicates a dual regulatory
role in membrane binding and nucleo-cytoplasmic shuttling of these proteins (Williams, 2003).
5.2. Polybasic motifs as a mechanism for nuclear protein-PPIn interaction
In the case of true nuclear proteins, i.e. residing dominantly in the nucleus, only a few are known to interact with PPIn. via a
structured domain. For example, basic residues in the PH domain of Tfb1 (p62), a subunit of the general transcription factor II H
(TFIIH) interacts preferably with PtdIns3P and PtdIns5P, and interaction with PtdIns5P could potentially regulate its binding with the
activation domain of VP16 due to an overlapping interaction site (Di Lello et al., 2005). PtdIns(3,4,5)P3 binding protein (PIP3BP)
binds to PtdIns(3,4,5)P3 via two individual PH domains (Tanaka et al., 1997, 1999). Consistently, in our study, only seven of the 349
proteins identified following neomycin displacement contained structured PPIn-binding domains, whereas 165 contained at least one
basic PPIn-binding K/R motif (Lewis et al., 2011). Furthermore, 19 of the 28 nuclear PtdIns(4,5)P2 specific-binding proteins con-
tained these motifs. Using mutational studies, we have subsequently verified the involvement of PBR or K/R motifs in PPIn binding in
three proteins identified, namely EBP1 (Karlsson et al., 2016), heterogeneous nuclear ribonucleoprotein U (hnRNP U) and Topo IIα
(unpublished results). EBP1 harbours two K/R motifs, one localised in the unstructured C-terminus and a reversely orientated K/R
motif in the N-terminus on a protruding loop (Table 4 (Karlsson et al., 2016)). Both of these K/R motifs contributed to PPIn binding as
site-directed mutations of lysine residues to alanines in both motifs were required to prevent PPIn binding of the full length protein
(Karlsson et al., 2016). The contribution of K/R motifs or PBRs in PPIn binding has also been demonstrated in a number of other
nuclear proteins, hence underscoring the relevance of electrostatic interactions for PPIn-binding in the nucleus. These include ING2
(Bua et al., 2013; Gozani et al., 2003), PHD factor 1 (Pf1) (Kaadige and Ayer, 2006), SAP30L (Viiri et al., 2009), UHRF1 (Gelato et al.,
2014), TAF3 (Stijf-Bultsma et al., 2015), BAZ2B (Kostrhon et al., 2017), PHF8 (Ulicna et al., 2018) as well as p53 (Choi et al., 2019)
and all require basic residues for the interaction (see Table 4). For example, PHF8 contains two K/R motifs and one PHD, but only the
most C-terminal K/R motif was found to bind to PtdIns(4,5)P2. This binding was abolished by mutating all the lysine residues to
alanine or glycine within the motif (Ulicna et al., 2018). In the case of Pf1, a PBR located C-terminal of a PHD zinc finger was shown
to be essential for PPIn binding while the PHD showed little contribution (Kaadige and Ayer, 2006). Basic residues have also been
shown to be important for PPIn-binding in other nuclear proteins such as nucleophosmin, which binds via two lysine pairs within its
C-terminus but in the absence of defined PPIn-binding motif (Ahn et al., 2005). Another example is Aly, which binds via basic residues
in a glycine-arginine-rich domain in its N-terminal (Okada et al., 2008). O-linked beta-N-acetylglucosamine transferase (OGT), on the
other hand, involves two lysines within a reverse K/R motif (Yang et al., 2008).
In addition to electrostatic properties of the PBR, other features or structures can influence PPIn interaction with nuclear proteins.
The contribution of hydrophobic regions is one of these features as shown in a number of nuclear PtdIns(3,4,5)P3-binding proteins, as
this permits interaction with acyl chains (Bidlingmaier et al., 2011). NMR analysis of the C-terminal PBR of EBP1 showed that
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hydrophobic interactions between non-polar residues upstream of the motif, particularly 356ALL358, and acyl chains of 16 carbons
contributed to binding to PtdIns(3,4,5)P3 in addition to electrostatic interactions ((Karlsson et al., 2016), as illustrated in Fig. 2B).
Consistently, a hydrophobic region upstream of the PBR is required for the ability of SAP30L to bind monophosphorylated PPIn, as
the PBR alone was unable to bind PPIn unless this hydrophobic region was also present (Viiri et al., 2009). In one instance, binding of
the repressor BASP1 to PtdIns(4,5)P2 requires the covalent binding of a myristoyl group within the region required for PPIn inter-
action (Terashita et al., 2002; Toska et al., 2012). Alternatively, PBR-mediated PPIn interaction can be influenced by the presence of a
zinc finger of the PHD type, located N-terminal to the PBR. This is the case for ING2 as shown in Fig. 2C, as well as in ING1, ACF1
(alias BAZ1A), and TAF3, implying a common mechanism (Gozani et al., 2003; Stijf-Bultsma et al., 2015). Molecular modelling of the
PHD-PBR of ING2 with PtdIns5P showed that, in at least one of the models, the PBR forms a PPIn binding pocket which encases the
inositol ring while one of the acyl chains is oriented towards the PHD ((Huang et al., 2007), as illustrated in Fig. 2C). The basic linker
region between the PHD domain and the bromodomain of BROMO domain adjacent to zinc finger 2B (BAZ2B) interacts with PPIn via
different K/R motifs and via the contribution of the proximal part of the PHD (Kostrhon et al., 2017). Similarly, SAP30L, display an
atypical zinc-finger followed by a PBR, which has also been recognised as a PPIn-interacting module, particularly to monopho-
sphorylated PPIn (Viiri et al., 2009). Interestingly, the zinc finger was shown to support PPIn interaction mediated by the PBR while
the PBR was required for PPIn specificity. Again, the PBR of Pf1 and ING2 play a major role in direct PPIn binding particularly in
determining PPIn specificity (Kaadige and Ayer, 2006). These studies emphasise that PBRs are key to PPIn binding and the en-
vironment and features around these regions can sometime influence binding, perhaps by shielding acyl chains.
As shown in Table 4, it is interesting to notice that many reported nuclear PPIn-binding proteins harbour K/R motifs that were
initially shown as a binding site for both PtdIns(4,5)P2 and actin in ABP. As discussed earlier, BRG1 is an example of a nuclear protein
which harbours such a motif showing the same binding activity to PtdIns(4,5)P2 and actin (Rando et al., 2002). Considering the
accumulating roles of both PPIn and actin in nuclear processes, it may be worth evaluating both their contribution when char-
acterising the functions of PPIn-effector proteins in the nucleus.
5.3. Influence of PPIn-mediated interaction on nuclear localisation
A few different studies have indicated that PPIn can influence the nuclear localisation of some PPIn-interacting proteins due to the
presence of basic residues in structured domains or short polybasic motifs. In particular, K/R motifs and PBRs bear resemblance to
NLS, i.e. the bipartite NLS (KR-(X9-29)-KKK and monopartite K-K/R-X-K/R, and nucleolar localisation signals (NoLS), such as R/K-R/
K-X-R/K (Emmott and Hiscox, 2009; McLane and Corbett, 2009). For example, the C-terminal K/R motif of EBP1 overlaps with a
NoLS and was shown to be required for both nucleolar targeting and PPIn binding via four lysines (Karlsson et al., 2016). The PBR in
SAP30L and BASP1 serves both as a NLS and PPIn binding site (Terashita et al., 2002; Toska et al., 2012; Viiri et al., 2009). The PPIn
binding site within the PH domain of the nuclear protein PIKE-L is also a putative NLS (Hu et al., 2005). Incidentally, disruption of
PPIn binding can translocate nuclear effector proteins from the nucleus to the cytoplasm. Mutation of the PPIn binding site in the PH
domain of PIKE-L causes its translocation to the cytoplasm (Hu et al., 2005). Mutation of the PBR which binds PtdIns(4,5)P2 in the C-
terminal of p53 also caused an increased distribution of p53 to the cytoplasm (Choi et al., 2019). As mentioned earlier, decreased
levels of PtdIns5P releases ING2 from the chromatin leading to its translocation to the cytoplasm, suggesting that the localisation of
ING2 is dependent upon PtdIns5P (Gozani et al., 2003; Jones et al., 2006). This was further substantiated by the effect of synthetic
PtdIns5P, as well as other PPIn, on the sub-nuclear targeting of fluorescently labelled NLS-PHD finger of ING2, which was altered in
the wild type but not in the PPIn binding mutant (Gozani et al., 2005). Similarly, PIP3BP, which harbours two PH domains, both
necessary for PtdIns(3,4,5)P3 binding, is translocated from the nucleus to the cytoplasm upon the introduction of constitutively active
PI3K, which is prevented by loss of the PH domain binding to PPIn (Tanaka et al., 1997, 1999). Another protein, OGT translocates
from the nucleus to the plasma membrane upon serum stimulation in a PtdIns(3,4,5)P3-dependent manner (Yang et al., 2008).
Disruption of PPIn binding can also affect sub-nuclear localisation. For example, alteration of the basic motif of Aly prevents its
localisation to nuclear speckles, redistributing it to the nucleoplasm (Okada et al., 2008). Insulin receptor substrate 3 (IRS3) can
localise both to the plasma membrane and to nuclear speckles and contains a PH domain which binds mostly to PtdIns3P, in contrast
to the PH domains of IRS1 and 2 which demonstrate different PPIn specificities (Maffucci et al., 2003; Razzini et al., 2000). A point
mutation in the PH domain, which abolishes PtdIns3P binding, decreases the localisation of full-length IRS3 to both the plasma
membrane and the nuclear speckles (Maffucci et al., 2003). PDZ (postsynaptic density protein-95, discs large, zonula occludens)
domains, which can bind to PPIn, including PtdIns(4,5)P2, have been suggested to localise zonula occludens 2 (ZO-2) to nuclear
speckles (Meerschaert et al., 2009) and syntenin-2 to nuclear speckles but most likely to nucleoli (Geeraerts et al., 2013; Mortier et al.,
2005). Finally, the pericentric heterochromatin localisation of UHRF1 is dependent upon an intact PPIn-binding PBR, at least due to
PtdIns5P (Gelato et al., 2014).
These studies may implicate a role for nuclear PPIn to compete with interacting partners or induce conformation changes of
effector proteins to allow their redistribution within the nucleus or even as far as to the cytoplasm and on the plasma membrane. The
fact that PPIn can target the same protein on membranes as well as in membrane-less sub nuclear sites is, however, a paradox but
appears to require similar binding strategies, as found in peripheral proteins and ABPs.
6. Conclusions
Mounting evidence have clearly shown that, just as cytoplasmic PPIn, nuclear PPIn can provide a signalling code allowing the
regulation of diverse nuclear processes. Still, many questions are unanswered regarding their functional characterisation. Continuous
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research efforts focusing on mapping the effector proteins of all known nuclear PPIn as well as deciphering their mode of interaction
are needed to increase our understanding of PPIn signalling in the nucleus.
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